Lung resident mesenchymal cells isolated from patients with the Bronchiolitis Obliterans Syndrome display a deregulated epigenetic profile
Abstract Bronchiolitis Obliterans Syndrome is the major determinant of the graft function loss after lung transplantation, but its pathogenesis is still incompletely understood and currently available therapeutic strategies are poorly effective. A deeper understanding of its pathogenic mechanisms is...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2018-07-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-018-29504-5 |
id |
doaj-42b1010b154e4e2f804bbd54ef3d9cd0 |
---|---|
record_format |
Article |
spelling |
doaj-42b1010b154e4e2f804bbd54ef3d9cd02020-12-08T04:10:54ZengNature Publishing GroupScientific Reports2045-23222018-07-018111310.1038/s41598-018-29504-5Lung resident mesenchymal cells isolated from patients with the Bronchiolitis Obliterans Syndrome display a deregulated epigenetic profileSerena Vella0Pier Giulio Conaldi1Emanuela Cova2Federica Meloni3Rosa Liotta4Salvatore Cuzzocrea5Lavinia Martino6Alessandro Bertani7Angelo Luca8Patrizio Vitulo9Department of Laboratory Medicine and Advanced Biotechnologies, IRCCS-ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione)Department of Laboratory Medicine and Advanced Biotechnologies, IRCCS-ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione)Department of Respiratory Diseases, IRCCS San Matteo Foundation and University of PaviaDepartment of Respiratory Diseases, IRCCS San Matteo Foundation and University of PaviaDepartment of Diagnostic and Therapeutic Services, Pathology Service, IRCCS-ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione)Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of MessinaDepartment for the Treatment and Study of Cardiothoracic Diseases and Cardiothoracic Transplantation, IRCCS-ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione)Department for the Treatment and Study of Cardiothoracic Diseases and Cardiothoracic Transplantation, IRCCS-ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione)Department of Diagnostic and Therapeutic Services, Radiology Service, IRCCS-ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione)Department for the Treatment and Study of Cardiothoracic Diseases and Cardiothoracic Transplantation, IRCCS-ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione)Abstract Bronchiolitis Obliterans Syndrome is the major determinant of the graft function loss after lung transplantation, but its pathogenesis is still incompletely understood and currently available therapeutic strategies are poorly effective. A deeper understanding of its pathogenic mechanisms is crucial for the development of new strategies to prevent and treat this devastating complication. In this study, we focused on the mesenchymal stromal cells, recently recognized as BOS key effectors, and our primary aim was to identify their epigenetic determinants, such as histone modifications and non-coding RNA regulation, which could contribute to their differentiation in myofibroblasts. Interestingly, we identified a deregulated expression of histone deacetylases and methyltransferases, and a microRNA-epigenetic regulatory network, which could represent novel targets for anti-fibrotic therapy. We validated our results in vitro, in a cell model of fibrogenesis, confirming the epigenetic involvement in this process and paving the way for a new application for epigenetic drugs.https://doi.org/10.1038/s41598-018-29504-5 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Serena Vella Pier Giulio Conaldi Emanuela Cova Federica Meloni Rosa Liotta Salvatore Cuzzocrea Lavinia Martino Alessandro Bertani Angelo Luca Patrizio Vitulo |
spellingShingle |
Serena Vella Pier Giulio Conaldi Emanuela Cova Federica Meloni Rosa Liotta Salvatore Cuzzocrea Lavinia Martino Alessandro Bertani Angelo Luca Patrizio Vitulo Lung resident mesenchymal cells isolated from patients with the Bronchiolitis Obliterans Syndrome display a deregulated epigenetic profile Scientific Reports |
author_facet |
Serena Vella Pier Giulio Conaldi Emanuela Cova Federica Meloni Rosa Liotta Salvatore Cuzzocrea Lavinia Martino Alessandro Bertani Angelo Luca Patrizio Vitulo |
author_sort |
Serena Vella |
title |
Lung resident mesenchymal cells isolated from patients with the Bronchiolitis Obliterans Syndrome display a deregulated epigenetic profile |
title_short |
Lung resident mesenchymal cells isolated from patients with the Bronchiolitis Obliterans Syndrome display a deregulated epigenetic profile |
title_full |
Lung resident mesenchymal cells isolated from patients with the Bronchiolitis Obliterans Syndrome display a deregulated epigenetic profile |
title_fullStr |
Lung resident mesenchymal cells isolated from patients with the Bronchiolitis Obliterans Syndrome display a deregulated epigenetic profile |
title_full_unstemmed |
Lung resident mesenchymal cells isolated from patients with the Bronchiolitis Obliterans Syndrome display a deregulated epigenetic profile |
title_sort |
lung resident mesenchymal cells isolated from patients with the bronchiolitis obliterans syndrome display a deregulated epigenetic profile |
publisher |
Nature Publishing Group |
series |
Scientific Reports |
issn |
2045-2322 |
publishDate |
2018-07-01 |
description |
Abstract Bronchiolitis Obliterans Syndrome is the major determinant of the graft function loss after lung transplantation, but its pathogenesis is still incompletely understood and currently available therapeutic strategies are poorly effective. A deeper understanding of its pathogenic mechanisms is crucial for the development of new strategies to prevent and treat this devastating complication. In this study, we focused on the mesenchymal stromal cells, recently recognized as BOS key effectors, and our primary aim was to identify their epigenetic determinants, such as histone modifications and non-coding RNA regulation, which could contribute to their differentiation in myofibroblasts. Interestingly, we identified a deregulated expression of histone deacetylases and methyltransferases, and a microRNA-epigenetic regulatory network, which could represent novel targets for anti-fibrotic therapy. We validated our results in vitro, in a cell model of fibrogenesis, confirming the epigenetic involvement in this process and paving the way for a new application for epigenetic drugs. |
url |
https://doi.org/10.1038/s41598-018-29504-5 |
work_keys_str_mv |
AT serenavella lungresidentmesenchymalcellsisolatedfrompatientswiththebronchiolitisobliteranssyndromedisplayaderegulatedepigeneticprofile AT piergiulioconaldi lungresidentmesenchymalcellsisolatedfrompatientswiththebronchiolitisobliteranssyndromedisplayaderegulatedepigeneticprofile AT emanuelacova lungresidentmesenchymalcellsisolatedfrompatientswiththebronchiolitisobliteranssyndromedisplayaderegulatedepigeneticprofile AT federicameloni lungresidentmesenchymalcellsisolatedfrompatientswiththebronchiolitisobliteranssyndromedisplayaderegulatedepigeneticprofile AT rosaliotta lungresidentmesenchymalcellsisolatedfrompatientswiththebronchiolitisobliteranssyndromedisplayaderegulatedepigeneticprofile AT salvatorecuzzocrea lungresidentmesenchymalcellsisolatedfrompatientswiththebronchiolitisobliteranssyndromedisplayaderegulatedepigeneticprofile AT laviniamartino lungresidentmesenchymalcellsisolatedfrompatientswiththebronchiolitisobliteranssyndromedisplayaderegulatedepigeneticprofile AT alessandrobertani lungresidentmesenchymalcellsisolatedfrompatientswiththebronchiolitisobliteranssyndromedisplayaderegulatedepigeneticprofile AT angeloluca lungresidentmesenchymalcellsisolatedfrompatientswiththebronchiolitisobliteranssyndromedisplayaderegulatedepigeneticprofile AT patriziovitulo lungresidentmesenchymalcellsisolatedfrompatientswiththebronchiolitisobliteranssyndromedisplayaderegulatedepigeneticprofile |
_version_ |
1724392224538492928 |